Debiopharm Innovation Fund and Philips Health Technology Ventures both contributed to the latest round for the cancer care software producer.
US-based cancer care technology developer Carevive Systems has raised an amount indicated by a securities filing to be $15m, in a series C round featuring corporate investors Debiopharm and Philips.
Investment firm Cerner Capital, venture capital firm HLM Venture Partners and VC investment platform LRVHealth also took part in the round along with Carevive’s co-founder and CEO, Madelyn Trupkin Herzfeld.
Biopharmaceutical company Debiopharm and electronics and medical device producer Philips participated through subsidiaries Debiopharm Innovation Fund and Philips Health Technology…
